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Objective: This study aimed to examine the association of Test Your Memory (TYM)-defined cognitive
impairment groups with known sociodemographic and cardiometabolic correlates of cognitive impairment
in a population-based study of older adults.
Methods: Participants were members of the British Regional Heart Study, a cohort across 24 British towns
initiated in 1978–1980. Data stemmed from 1570 British men examined in 2010–2012, aged 71–92years.
Sociodemographic and cardiometabolic factors were compared between participants defined as having
TYM scores in the normal cognitive ageing, mild cognitive impairment (MCI) and severe cognitive im-
pairment (SCI) groups, defined as ≥46 (45 if ≥80years of age), ≥33 and <33, respectively.
Results: Among 1570 men, 636 (41%) were classified in the MCI and 133 (8%) in the SCI groups. Com-
pared with participants in the normal cognitive ageing category, individuals with SCI were characterized
primarily by lower socio-economic position (odds ratio (OR)=6.15, 95% confidence interval (CI) 4.00–
9.46), slower average walking speed (OR=3.36, 95% CI 2.21–5.10), mobility problems (OR=4.61, 95%
CI 3.04–6.97), poorer self-reported overall health (OR=2.63, 95% CI 1.79–3.87), obesity (OR=2.59,
95% CI 1.72–3.91) and impaired lung function (OR=2.25, 95% CI 1.47–3.45). A similar albeit slightly
weaker pattern was observed for participants with MCI.
Conclusion: Sociodemographic and lifestyle factors as well as adiposity measures, lung function and poor
overall health are associated with cognitive impairments in late life. The correlates of cognitive abilities
in the MCI and SCI groups, as defined by the TYM, resemble the risk profile for MCI and Alzheimer’s
disease outlined in current epidemiological models.# 2015 The Authors. International Journal of Geri-
atric Psychiatry Published by John Wiley & Sons, Ltd.
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Introduction
Current global estimates suggest that 25–35 million
people are currently affected by severe cognitive
impairments (SCI) (Qiu et al., 2009; World Health
Organization, 2012), the most common form being
Alzheimer’s disease (AD) (Plassman et al., 2007).
Established correlates for AD or even milder declines
in cognitive abilities in late life include low physical
activity (Winchester et al., 2013), impaired motor
(Mirelman et al., 2014) and lung function (Bozek and
Jarzab, 2011), and smoking (Anstey et al., 2007; Peters
et al., 2008) as well as a positive history of
cardiovascular diseases (CVD) (de la Torre, 2004)
and/or diabetes (Tolppanen et al., 2013). Patients with
cognitive impairments are also more likely to report
poorer overall health (Montlahuc et al., 2011), sleep
disturbances (Ownby et al., 2014) and higher levels of
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functional dependence (Aguero-Torres et al., 1998).
However, it remains unclear whether AD is associated
with late-life hypertension (Power et al., 2011), hyper-
cholesterolaemia (Polidori et al., 2012) and obesity
(Anstey et al., 2011).
The past four decades have seen growing interest in
developing easy-to-administer cognitive screening
tools with clinical utility for primary and secondary
care settings (Larner, 2013; Zygouris and Tsolaki,
2014). One of the most promising tools is the Test
Your Memory (TYM) cognitive test (Brown et al.,
2009), which has sound psychometric properties
(Brown et al., 2009; Hancock and Larner, 2011),
remarkable cross-cultural validity (Hanyu et al.,
2011; Abd-Al-Atty et al., 2012; Szczesniak et al.,
2013; Ferrero-Arias and Turrion-Rojo, 2014; Iatraki
et al., 2014; Muñoz-Neira et al., 2014; Postel-Vinay
et al., 2014) and good concurrent validity with
established tests, such as the Mini-mental state
examination, and the Addenbrooke’s cognitive examina-
tion test battery (Brown et al., 2009; van Schalkwyk et al.,
2012; Koekkoek et al., 2013). However, studies using the
TYM were conducted among small clinical samples and
did not report on the sociodemographic and cardiomet-
abolic correlates of TYM-defined cognitive groups.
In this study, we investigated whether the established
risk pattern for late-life mild cognitive impairments
(MCI) and SCI is the same in a general population sam-
ple of British men aged 71–92years assessed with the
TYM. In particular, we sought (a) to characterize the
cognitive profiles defined by the TYM in terms of their
sociodemographic and cardiometabolic correlates and
(b) to examine whether the sociodemographic and
cardiometabolic profile of TYM-defined cognitive
impairments is similar to the ones reported in studies
employing different classification criteria to define
groups with MCI or SCI. Data included sociode-
mographic, lifestyle and overall health characteristics,
health service use, adiposity measures, cardiovascular risk
factors or diseases, diabetes and bloodmarkers. It was hy-
pothesized that these risk markers would be significantly
associated with differing abilities of cognitive functioning
as defined by the TYM, in line with the epidemiological
models proposed for patients with MCI and SCI.
Methods
The British Regional Heart Study (BRHS) is a prospec-
tive study including a socially and geographically
representative sample of 7735 men aged 40–59 years
recruited from 24 towns representative of all major
British regions. The BRHS commenced in 1978–1980
and did not cover the study of women (Walker et al.,
2004). In 2010–2012, all surviving men (n=3137)
aged 71–92 years were invited to attend a 30-year re-
examination (Figure 1). It was attended by 1722 BRHS
participants (55% response rate). Ethical approval was
provided by all relevant local research ethics commit-
tees. All men provided written informed consent to
the investigations, which were carried out in
accordance with the Declaration of Helsinki.
Physical examination of subjects involved anthropo-
metric (waist circumference) and physiological (blood
pressure, forced expiratory volume (FEV1) in 1s)
measurements as well as the calculation of body mass
index (BMI). Physical performance assessments in-
cluded a walking test, a chair rise test (time taken, in sec-
onds, to sit down and stand up five times from a chair
with the arms folded across the chest) and grip strength.
The details of these assessments have been described
elsewhere (Ramsay et al., 2014).
Cognitive skills were assessed using the TYM
(Brown et al., 2009). The TYM is a 10-task self-
assessment test that covers a broad range of cognitive
domains including orientation, copying, semantic
knowledge, calculation, fluency, similarities, naming,
visuospatial abilities, anterograde memory and execu-
tive functioning (Brown et al., 2009). The last item is
scored according to whether the TYM was completed
with help from others or not (major=1 to none=5).
Because participants completed the TYM in a con-
trolled setting without assistance, the maximum score
of 5 was given to all participants for this item. Total
Figure 1 Recruitment and retention flow chart for the 30-year replica-
tion of the British Regional Heart Study (2010–2012).
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TYM scores range between 0 and 50 with higher scores
indicating superior cognitive performance. Upon
calculating the total TYM scores, participants were
divided into three categories: a normal cognitive
ageing group, a group with MCI and one with SCI.
Cut-offs for the respective categories were based on
the original TYM scores (Brown et al., 2009; Royal
College of Psychiatrists (RPsych)). Specifically, scores
below 33 were considered consistent with SCI, while
scores between 33 and 45 (if older than 80years of
age) or 46 (if younger than 80years of age) were
considered to be indicative of MCI.
Socio-economic position was defined based on the
longest-held occupation of subjects at study entry
(aged 40–59years) in accordance to the Registrar
Generals’ Social Class Classification and has been
described elsewhere (Wannamethee et al., 1996).
Blood measurements
Assessments of high-density lipoprotein cholesterol,
triglycerides and glucose have been described in a
previous study (Ramsay et al., 2014). Insulin resistance
was estimated according to the homeostasis model assess-
ment as the product of fasting glucose (mmol/l) and
insulin (μU/ml) divided by the constant 22.5 (Ferrara
and Goldberg, 2001).
Lifestyle factors
Subjects were asked detailed questions about their
smoking and drinking habits as well as their pattern
of physical activity. These variables have been
described in a previous study (Ramsay et al., 2014).
Sleep quality was assessed using a self-reported
measure of the quality of sleep ranging from 1 ‘excel-
lent’ to 4 ‘poor’ as well as a self-reported measure of
the average hours of the daytime and night-time
sleep. To assess social interactions, a modified version
of the social engagement scale developed for the
Nottingham Activity and Ageing Study (Harwood
et al., 2000) was used; participants were asked
whether they spend any time (a) with family, friends
and neighbours, (b) with friends/relatives on the
telephone, (c) in paid work, (d) in voluntary work,
(e) in a pub or club, (f) attending religious services,
(g) playing cards, games or bingo, (h) reading or (i)
attending class or course of study. The sum of these
questions ranged from 0 to 9 and scores≤3 indicated
low social interactions.
Overall health, disabilities and health service use
History of cardiovascular disorders, that is, myocardial
infarction, heart failure, stroke, angina and diabetes,
was collected using information from the participants’
general practitioner record reviews prior to their
physical examination date. Participants were classified
as having a disability if they reported difficulties in
carrying out any of the following activities as a result
of a long-term health problem: going up or down
stairs, bending down, straightening up, keeping
balance, going out of the house or walking 400 yards.
Mobility problems were defined as not being able to
walk more than 200 yards, not being able to walk up
and down a flight of 12 stairs without resting or not
being able to bend down and pick up a shoe from
the floor. Overall health was assessed using the
number of general practitioner consultations in the
last year, as well as using a self-report health scale
ranging from 0 (worst imaginable health state) to
100 (best imaginable health state). Depressive symp-
tomatology was assessed using the four-item Geriatric
Depression Scale (D’Ath et al., 1994), a short instru-
ment consisting of four questions based on the early
work of Yesavage et al. (1982), which has been shown
to have good sensitivity and specificity rates for the
detection of depression in ill geriatric patients (Shah
et al., 1997). Scores for this scale range from 0 to 4
with scores >2 being indicative of depression.
Cut-offs used for cardiometabolic characteristics
The definitions used to identify patients with hyper-
tension as well as the cut-offs for low levels of high-
density lipoprotein cholesterol and high levels of
triglycerides have been described elsewhere (Ramsay
et al., 2014). Impaired fasting glucose was taken as
>6.1 and <7mmol/l. Low FEV1 was defined as being
in the lowest quintile of FEV1.
Statistical analysis
Statistical analysis was conducted in four stages. First,
the internal consistency of the items comprising the
TYM was examined using Cronbach’s alpha. Next,
the proportion (%) of participants classified in each
respective group (normal cognitive ageing, MCI or
SCI) was computed. Third, the proportion (%) of
participants who scored the maximum possible points
in each TYM item across groups was computed to
identify the affected cognitive domains. Finally, multi-
ple logistic regressions were performed to estimate
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age-adjusted odds ratios (ORs) and 95% confidence
intervals (CI) for sociodemographic and cardiometa-
bolic characteristics according to categories of cogni-
tive impairment using ‘normal cognitive ageing’ as
the reference group. The p-value for linear trend was
computed for all regression models and compared
with a significance level adjusted for multiple compar-
isons (=0.002). Additional regression models were run
for analyses examining the relationships between
blood measures and cognitive functioning upon ad-
justment for adiposity measures because excess weight
has been associated with insulin resistance and hyper-
cholesterolaemia (Bagi, 2009). All analyses were
carried out using STATA/IC 13 (Stata Corp, College
Station, TX, USA).
Results
The analyses for this study were restricted to 1570
participants who completed the TYM. Items compris-
ing the TYM presented with satisfactory internal con-
sistency (Cronbach’s α=0.72).
Of the 1570 men aged 71–92years, 801 (51%) had
cognitive skills in the normal cognitive ageing range
(M=47.73, SD=1.49), while 636 (41%) had MCI
(M=41.21, SD=3.13) and 133 (8%) SCI (M=27.43,
SD=5.33). Results of a one-way analysis of variance
suggested that the mean differences in the TYM scores
were statistically significant between groups (F(2,
1567)=3469.18, p<0.001; p-values of all pairwise
comparisons <0.001). Table 1 summarizes the pro-
portions (%) of participants who scored the maxi-
mum possible points for items assessing different
cognitive domains. The results suggest that for all
items comprising the TYM, higher rates of partici-
pants classified in the normal cognitive ageing group
were able to obtain maximum scores (proportions of
people scoring maximum points ranged from 55% to
78%), followed by those with MCI (22–39%) and
SCI (0–6%).
Table 2 presents the age-adjusted sociodemographic
characteristics and lifestyle factors of the three cognitive
function groups. Compared with participants in the nor-
mal cognitive ageing group, those with SCI were more
likely to be of manual social class, physically inactive
and ex-smokers. In addition, they were more prone to
report worse sleep quality, fewer hours of night-time
and more hours of daytime sleep as well as limited social
interactions. With the exception of the duration of
night-time sleep, the relationships were also significant,
albeit slightly weaker, for participants with MCI.
Table 1 Overall cognitive performance and score per cognitive domain across cognitive performance groups defined using the TYM in a population-
based study of 1570 older British men aged 71–92 years
Normal cognitive
ageing (n = 801, 51%)
Mild cognitive
impairment (n = 636, 41%)
Severe cognitive
impairments (n = 133, 8%)
Total sample
(n = 1570)
Overall cognitive performance
Total TYM score
(M ±SD)*
47.73 ± 1.49 41.21 ± 3.13 27.43 ± 5.33 43.37 ± 6.38
Affected cognitive domains
Orientation n (%) with
highest score (=10)
698 (58%) 438 (36%) 66 (5%) 1202 (77%)
Copying n (%) with
highest score (=2)
778 (55%) 556 (39%) 77 (5%) 1411 (90%)
Semantic knowledge
n (%) with highest score (=3)
574 (67%) 241 (28%) 37 (4%) 852 (54%)
Calculation n (%) with
highest score (=4)
630 (58%) 399 (37%) 55 (5%) 1084 (69%)
Fluency n (%) with
highest score (=4)
661 (69%) 276 (29%) 24 (3%) 961 (61%)
Similarities n (%) with
highest score (=4)
653 (65%) 318 (32%) 29 (3%) 1000 (64%)
Naming n (%) with
highest score (=5)
719 (57%) 497 (39%) 48 (4%) 1264 (81%)
Visuospatial 1 n (%) with
highest score (=3)
719 (62%) 418 (36%) 19 (2%) 1156 (74%)
Visuospatial 2 n (%)
with highest score (=4)
712 (63%) 390 (35%) 29 (3%) 1131 (72%)
Anterograde memory
n (%) with highest score (=6)
504 (78%) 142 (22%) 1 (0%) 647 (41%)
TYM; Test Your Memory.
*p< 0.001.
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p-values for linear trend across ordered categories for
these risk factors were statistically significant and sur-
vived adjustments for multiple comparisons, suggesting
that risk exposure was systematically higher for partici-
pants in different cognitive groups (all p-values<0.002).
Table 3 presents the age-adjusted associations between
cognitive groups and history of CVD or diabetes, overall
health, health service use, physical performance and
disabilities. The results suggest that participants with
SCI were more likely to have a positive history of stroke
or diabetes or to report poorer overall health. Moreover,
their average walking speed was slower; they performed
poorly in the chair rise test, and they presented with
decreased mobility and problems with keeping balance,
as well as with other disabilities (all p-values <0.001).
Similarly, in comparison with participants in the normal
cognitive ageing group, those with MCI were more likely
to have a positive history of stroke and to report poorer
overall health, have slower average walking speed and
require longer times to complete the chair rise test. They
were also more prone to have problems with keeping
their balance and to have mobility problems and other
Table 3 History of CVD, service use, overall health, disabilities and physical performance across cognitive performance groups defined using the TYM
in a population-based study of 1570 older British men aged 71–92 years
Normal cognitive
ageing
(n = 801, 51%)
Mild cognitive
impairment
(n = 636, 41%)
Severe cognitive
impairments
(n = 133, 8%)
p-value‡
(linear trend)
History of CVD or diabetes
Myocardial infarction n (%)
Odds ratio (95% CI)
69 (9%)
1.00
59 (9%)
1.09 (0.75–1.56)
16 (12%)
1.43 (0.80–2.55)
0.25
Heart failure n (%)
Odds ratio (95% CI)
27 (3%)
1.00
34 (5%)
1.60 (0.95–2.69)
8 (6%)
1.74 (0.77–3.94)
0.05
Stroke n (%)
Odds ratio (95% CI)
32 (4%)
1.00
44 (7%)
1.80 (1.13–2.87)*
12 (9%)
2.41 (1.21–4.81)*
0.003
Diabetes n (%)
Odds ratio (95% CI)
91 (11%)
1.00
89 (14%)
1.29 (0.94–1.76)
23 (17%)
1.69 (1.03–2.80)*
0.03
Any CVD n (%) (MI, HF or stroke)
Odds ratio (95% CI)
117 (15%)
1.00
118 (19%)
1.33 (1.00–1.76)*
32 (24%)
1.82 (1.17–2.84)**
0.003
Service use and overall health
Number of GP consultations
in last year
Top quintile (≥6) n (%)
Odds ratio (95% CI)
136 (18%)
1.00
116 (20%)
1.17 (0.88–1.54)
29 (24%)
1.44 (0.92–2.29)
0.08
Poor overall health n (%)
Odds ratio (95% CI)
187 (24%)
1.00
188 (30%)
1.38 (1.09–1.75)**
59 (46%)
2.63 (1.79–3.87)**
<0.001
Depressive symptomatology n
(%) with score >2
Odds ratio (95% CI)
47 (6%)
1.00
38 (7%)
1.11 (0.72–1.74)
8 (7%)
1.17 (0.54–2.55)
0.56
Physical performance and disabilities
Walking speed (3 m)
Top quintile (≥4.12 s) n (%)
Odds ratio (95% CI)
116 (15%)
1.00
157 (25%)
1.93 (1.47–2.54)**
49 (37%)
3.34 (2.20–5.07)**
<0.001
Sit/stand five times
Top quintile (≥17.54 s) n (%)
Odds ratio (95% CI)
154 (19%)
1.00
178 (28%)
1.62 (1.26–2.08)**
35 (26%)
1.41 (0.91–2.17)
0.001
Grip strength Lower quintile
(<23) n (%)
Odds ratio (95% CI)
149 (19%)
1.00
139 (23%)
1.21 (0.93–1.57)
26 (20%)
0.97 (0.61–1.56)
0.30
Problem keeping balance n (%)
Odds ratio (95% CI)
87 (14%)
1.00
87 (19%)
1.43 (1.02–1.98)*
28 (29%)
2.47 (1.49–4.10)**
<0.001
Any disability n (%)
Odds ratio (95% CI)
222 (34%)
1.00
221 (44%)
1.49 (1.17–1.90)**
64 (55%)
2.30 (1.53–3.43)**
<0.001
Mobility problems n (%)
Odds ratio (95% CI)
116 (15%)
1.00
143 (24%)
1.81 (1.38–2.39)**
55 (45%)
4.61 (3.04–6.97)**
<0.001
All odds ratios are age-adjusted.
CVD, cardiovascular diseases; GP, general practitioner; MI, myocardial infarction; HF, heart failure; TYM, Test Your Memory; CI, confidence
interval.
*p< 0.05.
**p< 0.01.
‡p for linear trend across ordered categories.
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disabilities. p-values (trend across ordered groups) ad-
justed for multiple comparisons suggested that history
of stroke or CVDs was marginally associated with
cognitive groups (for both comparisons p=0.003); trend
p-values for all other associations, including poor overall
health, gait speed, problems with keeping balance,
disabilities and mobility problems survived adjustments
for multiple comparisons (<0.002)
Finally, Table 4 presents the age-adjusted compari-
sons of blood markers, blood pressure, adiposity mea-
sures and lung function in the three cognitive function
groups. Initial results showed that low high-density
lipoprotein and high insulin resistance were associated
with a higher probability of being in the SCI group.
However, after adjusting for BMI, the ORs associated
with these blood markers were no longer statistically
significant (OR=1.38, 95% CI 0.82–2.33; and
OR=1.39, 95% CI 0.85–2.27, respectively). In contrast,
obesity (BMI>30kg/m2) and high waist circumference
(>102cm) were significantly associated with SCI. Addi-
tionally, participants with SCI were more likely to have
lower FEV1 than those in the normal cognitive ageing
group. High blood pressure and other blood markers
were not significantly associated with cognitive function
group. Compared with participants in the normal
cognitive ageing group, those with MCI did not differ
significantly in any of the examined cardiometabolic risk
factors or adiposity measures. p-values (trend) adjusted
for multiple comparisons suggested that a BMI>30,
waist circumference>102 and membership in the
bottom quintile of FEV1 showed a statistically significant
trend across the different TYM-defined cognitive groups
(all p-values<0.002).
Discussion
This study in a representative sample of older British
men shows that numerous sociodemographic and car-
diometabolic factors are significantly associated with
MCI and SCI, as assessed using the TYM. The stron-
gest associations were observed for factors that have
also been associated with MCI and AD in different
studies and included low occupation-based socio-
Table 4 Cardiometabolic risk factors, adiposity measures and lung function across cognitive performance groups defined using the TYM in a
population-based study of 1570 older British men aged 71–92 years
Normal cognitive
ageing
(n = 801, 51%)
Mild cognitive
impairment
(n = 636, 41%)
Severe cognitive impairments
(n = 133, 8%)
p-value‡
(linear trend)
Cardiometabolic risk factors
Low HDL (<1.04mmol/l) n (%)
Odds ratio (95% CI)
92 (12%)
1.00
93 (15%)
1.31 (0.96–1.79)
24 (19%)
1.76 (1.07–2.89)*
0.01
High LDL (>4mmol/l) n (%)
Odds ratio (95% CI)
65 (9%)
1.00
52 (9%)
1.01 (0.69–1.47)
8 (7%)
0.76 (0.35–1.62)
0.60
High triglycerides (≥2.3mmol/l) n (%)
Odds ratio (95% CI)
53 (7%)
1.00
53 (9%)
1.30 (0.87–1.93)
11 (9%)
1.40 (0.71–2.77)
0.23
Total cholesterol (≥5mmol/l) n (%)
Odds ratio (95% CI)
306 (40%)
1.00
216 (36%)
0.82 (0.66–1.03)
38 (31%)
0.67 (0.44–1.01)
0.02
Impaired total fasting glucose
(<6.1 or >7.0mmol/l) n (%)
Odds ratio (95% CI)
73 (10%)
1.00
69 (12%)
1.18 (0.83–1.68)
11 (10%)
0.90 (0.46–1.76)
0.70
Insulin resistance, top quintile
(≥3.68mmol/l × μU/ml) n (%)
Odds ratio (95% CI)
126 (18%)
1.00
116 (20%)
1.17 (0.88–1.55)
34 (30%)
1.97 (1.26–3.08)**
0.01
High blood pressure n (%)
Odds ratio (95% CI)
545 (68%)
1.00
429 (68%)
0.97 (0.78–1.22)
92 (69%)
1.04 (0.70–1.55)
0.97
Adiposity measures and lung function
BMI ≥ 30 kg/m2n (%)
Odds ratio (95% CI)
137 (17%)
1.00
124 (20%)
1.19 (0.91–1.56)
44 (34%)
2.59 (1.72–3.91)**
<0.001
High waist circumference
(>102 cm) n (%)
Odds ratio (95% CI)
288 (36%)
1.00
259 (41%)
1.23 (1.00–1.53)
69 (52%)
1.98 (1.36–2.87)**
0.001
FEV1 Bottom quintile (≤1.93 l) n (%)
Odds ratio (95% CI)
139 (18%)
1.00
132 (22%)
1.25 (0.95–1.64)
42 (33%)
2.24 (1.46–3.43)**
<0.001
All odds ratios are age-adjusted.
HDL, high-density lipoprotein; LDL, low-density lipoprotein; TYM, Test Your Memory; CI, confidence interval.
*p< 0.05.
**p< 0.01.
‡p for linear trend across ordered categories.
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economic status (Karp et al., 2004), physical inactivity
(Winchester et al., 2013), motor (Mirelman et al.,
2014) and lung dysfunction (Bozek and Jarzab,
2011), smoking (Anstey et al., 2007; Peters et al.,
2008), positive history of CVD (de la Torre, 2004) or
diabetes (Tolppanen et al., 2013), poor overall health
(Montlahuc et al., 2011), sleep disturbances (Ownby
et al., 2014) and higher levels of functional depen-
dence related to abilities to perform everyday activities
(Aguero-Torres et al., 1998; Femminella et al., 2014).
These correlates showed a significant ordered trend
across cognitive groups suggesting a systematically in-
creased likelihood of presenting with MCI and SCI.
Comparison with other studies
While some of the significant correlates of cognitive
functioning assessed with the TYM were consistent
with findings from the available literature, late-life
hypertension (Power et al., 2011) and hypercholester-
olaemia (Polidori et al., 2012), which have shown con-
tradictory results with respect to incident AD, did not
emerge as significant characteristics in this study. In
addition, obesity was one of the strongest correlates
of SCI although a recent meta-analysis suggests that
primarily midlife rather than late-life obesity is associ-
ated with cognitive impairments (Anstey et al., 2011).
However, the cross-sectional design of this study did
not allow for the examination of the prospective rela-
tionships between these measures. Moreover, lung
function and adiposity measures were associated with
SCI but not MCI and might therefore serve as target
factors in future research on the differing manifesta-
tions and progress of MCI and AD. Two studies by
Scarmeas et al. (2009a, 2009b) in prospective cohort
samples of elders have also shown that BMI differs sig-
nificantly only between individuals with intact cogni-
tive skills and SCI, but not MCI (Scarmeas et al.,
2009a, 2009b). With respect to lung function, reduced
FEV1 rates in midlife were shown to be predictive of
MCI in a recent study (Vidal et al., 2013), while
declines in pulmonary function over an 8-year period
of time were not. The biological mechanisms underly-
ing these relationships are yet to be disentangled.
Strengths and limitations
This study is unique in terms of using the TYM in a
general population sample to assess cognitive abilities
in the elderly population. Previous studies using the
TYM were based on clinical or smaller probabilistic
samples and focused mainly on the discriminant
abilities of the TYM rather than the characteristics
associated with the cognitive groups assessed. More-
over, for this study, we assessed numerous
sociodemographic and cardiometabolic factors, and
therefore, it is an excellent inventory of cardiovascular
and related factors associated with cognitive
impairments.
The items of the TYM showed satisfactory internal
consistency (72%) in this general population sample.
While reliability rates between 78% and 98% have been
reported for the TYM in clinical samples (Abd-Al-Atty
et al., 2012; Muñoz-Neira et al., 2014), Charter (2003)
has noted that with low sample sizes, alpha coefficients
can be rather unstable (Charter, 2003); the reported
reliability of 0.72 might therefore represent a more
accurate estimate.
The BRHS is a highly representative sample of the
older male UK population, which has been successful
in keeping attrition rates at very low levels. However,
the issue of survivor bias cannot be overlooked in
cohorts of ageing populations; subjects with AD are
more likely to have died earlier (Weuve et al., 2014).
An additional limitation of the BRHS is that it com-
prises only men of predominantly White European
origin; therefore, the results cannot necessarily be
generalized to women and different ethnic groups.
For this study, total TYM scores were calculated,
which may have obscured findings on atypical, for ex-
ample non-amnestic, presentations of SCI. In fact, the
TYM includes items assessing visuospatial tasks, which
contribute 7/50 points and could help in distinguishing
between amnestic and non-amnestic (atypical) mani-
festations of MCI or SCI. However, non-amnestic AD
is less frequent than amnestic AD (Chertkow et al.,
2013). Additionally, the TYM is not a diagnostic tool,
and therefore, it is likely that study members with SCI
did not meet diagnostic criteria for AD or suffered
from other forms of dementia.
It is also likely that different cut-offs of the TYM to
define cognitive groups could be more sensitive for use
in general population samples. Yet, when we applied
the stricter cut-offs proposed by Hancock and Larner
(2011) to define cognitive groups in an exploratory
manner, the results were very similar to the ones
described for this study. In addition, these cut-offs
are less inclusive and could lead to less robust esti-
mates for the relationship estimates between cognitive
impairments and the correlates examined. As this is
the first study to administer the TYM to a general pop-
ulation sample, we could not calibrate new cut-offs for
use in general population samples in the absence of an
additional cognitive screening instrument and/or in-
formation on relevant clinical outcomes, for example
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AD. It is also acknowledged that assigning 5 points to
every participant for the last task of the TYM could be
a source of bias in terms of the classification obtained.
Nonetheless, a sensitivity analysis to examine the clas-
sification without assigning 5 points for this question
to the study members extracted a classification almost
identical to the one reported in the study. Finally, the
results presented are based on cross-sectional
assessments, and therefore, only associative but not
causative aetiological mechanisms can be inferred,
primarily because of possible temporal biases (reverse
causality).
Implications
The proportion of participants classified as having MCI
(41%) or SCI (8%) using the TYM in this sample is in
line with the prevalence rates for MCI and AD reported
in previous studies (Bischkopf et al., 2002; World
Health Organization, 2012). Available literature reports
that the respective prevalence rates for mild forms of
cognitive dysfunction and AD range between 2% and
56% (Bischkopf et al., 2002) and 2% and 8.5%, respec-
tively, for those aged 60years and over (World Health
Organization, 2012).
Moreover, previous studies, which report similar
cardiometabolic risk profiles for cognitive impair-
ments, have used different cognitive screening tools or
classification criteria to ascertain classifications of AD
or MCI, for example the Mini-mental state examina-
tion, the criteria of the joint-working group of the Na-
tional Institute of Neurological and Communicative
Disorders and Stroke and the Alzheimer’s Disease and
Related Disorders Association (McKhann et al., 1984)
and the Diagnostic and Statistical Manual of Mental
Disorders (Third Edition Revised) (APA, 1987). There-
fore, future research needs to compare the TYM against
established cognitive screening instruments and diag-
nostic tools to validate its potential as a highly reliable
cognitive test for use in general population samples.
Conclusion
This is the first study to utilize the TYM within a
population-based sample. It provides further evidence
that cognitive impairment among older adults is
associated with a range of sociodemographic and
cardiometabolic factors, particularly low occupation-
based socio-economic status, physical inactivity, mo-
tor and lung dysfunction, smoking, positive history
of CVD or diabetes, poor overall health, sleep distur-
bances and higher levels of functional dependence
related to abilities to perform everyday activities. The
cardiometabolic and sociodemographic correlates of
TYM-defined cognitive groups are almost identical to
those extracted using established screening and diag-
nostic tools. Targeting these risk factors that are mod-
ifiable would increase the scope for primary and
secondary interventions aiming to reduce the adverse
effects of dementia in the older population.
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correlates of TYM-defined cognitive groups in
this representative sample of older British men
are almost identical to those outlined in current
epidemiological models using established
cognitive screening tests.
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